| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.06 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.052 | 0.06 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.064 | 0.06 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.06 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.069 | 0.06 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.06 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.064 | 0.06 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.06 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.07 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.07 |